Age Data Research Articles

Timing of carbon uptake by oceanic crust determined by rock reactivity

Abstract Carbonate formation during the alteration of oceanic crust is a global CO2 sink. Its timing and controls are not well understood, particularly in volcanic seamounts, which react with seawater over tens of millions of years. We report in situ U-Pb age dates of carbonate vein and void fill in 50–74 Ma basaltic basement of the Louisville Seamount Chain. More than 90% of the carbonate formed <20 m.y. after seamount emplacement. Vesicle carbonate precipitated within 8 m.y. (median = 2.9 m.y.) whereas vein carbonate grew over longer time spans (median = 8.1 m.y.). The duration of carbonation was hence limited despite the basement’s long-term exposure to seawater. The age dates imply a rapid infill of vesicles by alteration of confined domains around vesicles. Carbonate formation in veins extended for longer periods of time, likely due to the late opening of fractures, which exposed fresh reactive rock surface to circulating seawater long after the formation of the basement. We suggest that carbonate growth ceased after the volcanic rocks were too altered to liberate sufficient Ca2+ and generate the alkalinity required for carbonate precipitation. A critical extent of rock reactivity is required to sustain carbonate formation. Carbonate precipitation likely ends after much of the exposed basaltic substrate has been altered and the rock reactivity drops below this critical threshold. These findings help to explain the generally short duration of carbonation in the flanks of mid-ocean ridges.

Age dating of liquid 90Sr–90Y sources

In the context of age dating of 90Sr, the selective adsorption of zirconium ions from the mixture with strontium and yttrium by adsorbents based on TiO2 with a chemically modified surface was investigated. The general features of the separation process of strontium, yttrium, and zirconium in batch conditions were determined. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) was used to analyze the initial and residual concentrations of the studied cations. Separation of 90Zr and 90Sr from a liquid source containing 90Sr–90Y using adsorbents based on TiO2 was performed for the first time. The ratio of 90Zr/90Sr was measured, and the age of liquid 90Sr–90Y sources was determined. In addition, we studied the age dating of 90Sr–90Y sources using a combination of liquid-scintillation counting of 90Sr and ICP-MS measurement. The results of both methods – the method of age-dating with the chemical separation of isotopes and the combination of LSC and ICP-MS analysis – agree very well and thus serve for cross-validation. Moreover, the combination of the two methods increases the confidence in the age-dating results of 90Sr–90Y sources.

An algorithm-based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example.

Improved hypereosinophilic syndrome (HES) ascertainment in electronic health record (EHR) databases may improve disease understanding and management. An algorithm to ascertain and characterize this rare condition was therefore developed and validated. Using the UK clinical practice research datalink (CPRD)-Aurum database linked to the hospital episode statistics database (Admitted Patient Care data) from Jan 2012 to June 2019, this cross-sectional study ascertained patients with a specific HES code (index). Patients with HES were matched (age, sex and index date) 1:29 with a non-HES cohort. An algorithm was developed by identifying pre-defined variables differing between cohorts; model-fitting using Firth logistic regression and statistical determination of the top-five performing models; and internal validation using Leave-One-Out Cross Validation. Final model sensitivity and specificity were determined at an 80% probability threshold. The HES and non-HES cohorts included 88 and 2552 patients, respectively; 270 models with four variables each (treatment used for HES, asthma code, white blood cell condition code, and blood eosinophil count [BEC] code) plus age and sex variables were tested. Of the top five models, the sensitivity model performed best (sensitivity, 69% [95% CI: 59%, 79%]; specificity, >99%). The strongest predictors of HES versus non-HES cases (odds >1000 times greater) were an ICD-10 code for white blood cell disorders and a BEC ≥1500 cells/μL in the 24 months pre-index. Using a combination of medical codes, prescribed treatments data and laboratory results, the algorithm can help ascertain patients with HES from EHR databases; this approach may be useful for other rare diseases.

Late Pleistocene clastic tufa from Gafsa, southern Tunisia: Implications for paleo-landscape interpretation

The landscape reconstruction in the Jebel El Mida area during the Late Pleistocene was based on the continental carbonate record, particularly on the clastic tufa deposits. Four main lithofacies types of clastic tufa were recorgnized in the Jebel El Mida area, these are: (1) grain-supported macrodetrital phytoclast tufa, (2) grain-supported macrodetrital oncolith tufa, (3) grain-supported macrodetrital lithoclast tufa, and (4) matrix-supported microdetrital tufa. The interpretation of depositional environment reveals spring-fed streams and pools with highly CO2-enriched water helped in carbonate precipitation and incrustation on the vegetation cover. Dating of tufa deposits has been based on archeological content and radiometric (U/Th) age dating. A major lag exists between the age of the archeological content and the radiometric age for tufa (170 ky) indicating transport and re-sedimentation of older reworked tufa within the stone tool-rich sandsone and conglomeratic substrates. The major fault of Gafsa that cross-cuts the studied area is the main conduit for upwelling carbonated waters for tufa precipitation and also the re-organization of the landscape after the recurrent tectonic activity during the Late Pleistocene. The deposition of Jebel El Mida tufa indicates particular depostional settings characterized by (1) abundant rainfall on the recharge areas with high water table, (2) acidic water infiltrations through plant cover and soils, and (3) dissolution of aquiferous Cretaceous carbonates resulting in water mineralization of the groundwater during a time span that predates Late Pleistocene.

A-03 Preliminary Evidence for Motor Vehicle Accidents and Associated Concussion Response Severity in Older Adults

Abstract Purpose To determine if mechanism of injury is associated with differences in initial response to concussion in older adults. Methods Fifty older adults (54% female) aged 50-84 (59.14±6.54) were recruited from a sports medicine concussion clinic at initial appointment. Inclusion criteria included age (50+) and injury date within the last year. Exclusion criteria included prior diagnosis of a neurological disorder and/or brain malformation, psychiatric diagnosis other than anxiety/depression, prior history of moderate or severe brain injury, and/or ongoing litigation. Mechanism of injury in the sample included 22 falls/accidents (44%), 20 MVAs (40%), 2 sport/recreation (4%), 1 assault (2%), and 5 other (10%). Participants were assigned to two independent groups, MVA and Non-MVA. Outcome measures included Vestibular/Ocular-Motor Screening (VOMS), Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), and Concussion Clinical Profile Screening (CP Screen). Response severity was operationalized by VOMS Total and CP Screen Total. Two-tailed independent t-tests (alpha<.05) examined differences between groups at initial visit. Results There were no significant differences between groups in terms of demographics or other common risk factors. There were no differences between groups for response severity. The MVA group reported more severe vestibular complaints t(41) =2.07, p=.044, more severe cognitive complaints, t(44)=3.68, p<.001, and demonstrated worse scores on domains of visual memory, t(43)=-2.16, p=.037, reaction time, t(43)=3.07, p=.004, and visual motor speed, t(43)=-2.85, p=.007. Conclusions MVA-related concussions may result in more focal disruption of vestibular and cognitive performance in older adults. Future research is warranted to confirm the findings of this study, to explore potential explanations for these findings, and to further explore how concussion presents in older adults.

Updated estimation of cutaneous leishmaniasis incubation period in French Guiana.

The cutaneous leishmaniasis (CL) incubation period (IP) is defined as the time between parasite inoculation by sandfly bite and the onset of the first CL lesion. IP distribution is difficult to assess for CL because the date of exposure to an infectious bite cannot be accurately determined in endemic areas. IP current estimates for CL range from 14 days to several months with a median around 30-60 days, as established by a few previous studies in both New and Old Worlds. We estimated CL incubation period distribution using time-to-event models adapted to interval-censored data based on declared date of travels from symptomatic military personnel living in non-endemic areas that were exposed during their short stays in French Guiana (FG) between January 2001 and December 2021. A total of 180 patients were included, of which 176 were men (97.8%), with a median age of 26 years. When recorded, the parasite species was always Leishmania guyanensis (31/180, 17.2%). The main periods of CL diagnosis spread from November to January (84/180, 46.7%) and over March-April (54/180, 30.0%). The median IP was estimated at 26.2 days (95% Credible Level, 23.8-28.7 days) using a Bayesian accelerated failure-time regression model. Estimated IP did not exceed 62.1 days (95% CI, 56-69.8 days) in 95% of cases (95th percentile). Age, gender, lesion number, lesion evolution and infection date did not significantly modify the IP. However, disseminated CL was significantly associated with a 2.8-fold shortening of IP. This work suggests that the CL IP distribution in French Guiana is shorter and more restricted than anticipated. As the incidence of CL in FG usually peaks in January and March, these findings suggest that patients are contaminated at the start of the rainy season.

Stellar Rotation and Structure of the α Persei Complex: When Does Gyrochronology Start to Work?

On the pre-main sequence, the rotation rates of Sun-like stars are dictated by the interplay between the protostellar disk and the star’s contraction. At ages exceeding 100 Myr, magnetic spindown erases the initial stellar spin rate and enables rotation-based age dating (gyrochronology). The exact time at which the transition between these two regimes occurs depends on stellar mass, and has been challenging to empirically resolve due to a lack of viable calibration clusters. The α Persei open cluster (t ≈ 80 Myr, d ≈ 170 pc) may provide the needed calibrator, but recent analyses of the Gaia data have provided wildly varying views of its age and spatial extent. As such, we analyze a combination of TESS, Gaia, and LAMOST data to calibrate gyrochronology at the age of α Per and to uncover the cluster’s true morphology. By assembling a list of rotationally confirmed α Per members, we provide strong evidence that α Per is part of a larger complex of similarly aged stars. Through kinematic back-integration, we show that the most diffuse components of α Per were five times closer together 50 Myr ago. Finally, we use our stellar rotation periods to derive a relative gyrochronology age for α Per of 67% ± 12% the age of the Pleiades, which yields 86 ± 16 Myr given current knowledge. We show that by this age, stars more massive than ≈0.8 M ⊙ have converged to form a well-defined slow sequence.

Diabetes treatment deintensification in Australians with dementia compared to the general population: A national cohort study.

Diagnosis of dementia may change peoples' goals of care. In people with diabetes, this may lead to relaxing treatment targets and reducing the use of diabetes medications. The aim of this study was to examine changes in diabetes medication use before and after initiating medication for dementia. A national cohort of people aged 65-97 years, living with dementia and diabetes, and a general population cohort with diabetes matched for age, sex, and index date were extracted from the Australian national medication claims database. Trajectories of diabetes medication use, expressed as mean defined daily dose (DDD) each month for each individual from 24 months before to 24 months after the index date, were estimated using group-based trajectory modeling (GBTM). Cohorts were analyzed separately. People with dementia (N = 1884) and the matched general population (N = 7067) had a median age of 80 years (interquartile range 76-84) and 55% were female. In both models, people exhibited one of five diabetes medication trajectories, with 16.5% of people with dementia and 24.0% of the general population assigned to trajectories that represented deintensification. In the general population model, those on deintensifying trajectories were older than those on stable trajectories (median 83 vs. 79 years). In the dementia cohort model, those on high or low deintensifying trajectories were slightly older (median age 81 or 82, respectively, vs. 80 years) and had at least 1 more comorbidity (median 8 or 7, respectively, vs. 6) than those on stable trajectories. Initiating medication for dementia does not appear to be a trigger for deintensification of diabetes treatment regimens. Deintensification was more common in the general population; people living with dementia are potentially overtreated for diabetes.

EPH113 Healthcare Utilization Remains Elevated Among People Living with Post-COVID-19 Condition More Than One Year after Acute COVID-19 Illness

Healthcare systems require comprehensive data for long-term resource allocation planning to support people living with post-COVID-19 condition (PCC). Limited information is available on long-term PCC-associated healthcare utilization patterns. In this study, we assess healthcare utilization rates six and 12-18 months following acute COVID-19 illness among COVID-19 survivors in British Columbia (BC), Canada by PCC status. We used difference-in-difference analysis to assess healthcare utilization by all adult COVID-19 survivors in BC diagnosed with COVID-19 on/before November 18, 2021 during three time periods: (i) 26 weeks after the first 4 weeks of COVID-19 illness, and that exact period (ii) one or two years prior (baseline), and (iii) one year afterwards. PCC/non-PCC patients were matched 1:2 on age, sex, region, comorbidities, vaccination status, and COVID-19 index date ±14 days. The total number of daily healthcare encounters (medical visit, emergency department visit, hospitalization) per person was calculated. Rate ratios (RR) for PCC-associated healthcare utilization were estimated using weighted Poisson regression. The matched cohort (n= 7,092) included 2,364 PCC patients (54.9% female; mean age 39.8 [SD, 13.4] years). Healthcare utilization rates were comparable between the PCC and non-PCC groups at baseline (average: 39.3 vs. 32.7 visits per 1000 patients, respectively), but rose two-fold for the PCC group during the 26-week period post-acute illness (76.1 vs. 33.5). One year later, PCC-associated healthcare utilization rates declined but remained elevated relative to baseline rates (54.6 vs. 34.4). In multivariable Poisson regression models, PCC was associated with a 103% increase in healthcare utilization over 26 weeks post-acute illness (aRR: 2.03, 95% CI 1.71-2.41) and a 24% increase the next year (aRR: 1.24, 95% CI 1.03-1.48). The increased healthcare utilization rates noted among PCC patients one year following acute COVID-19 illness highlights the need for adequate planning to provide optimal support for people living with PCC.

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study

We evaluated relative vaccine effectiveness (rVE) of 4- vs. 3-dose mRNA-1273 against SARS-CoV-2 infection, and COVID-19 hospitalization and death in immunocompetent adults aged ≥50 years at Kaiser Permanente Southern California. We included 178,492 individuals who received a fourth dose of mRNA-1273, and 178,492 randomly selected 3-dose recipients who were matched to 4-dose recipients by age, sex, race/ethnicity, and third dose date. Adjusted 4- vs. 3-dose rVE against SARS-CoV-2 infection, COVID-19 hospitalization, and COVID-19 hospitalization death were 25.9 % (23.5 %, 28.2 %), 67.3 % (58.7 %, 74.1 %), and 72.5 % (-35.9 %, 95.2 %), respectively. Adjusted rVE against SARS-CoV-2 infection ranged between 19.8 % and 39.1 % across subgroups. Adjusted rVE against SARS-CoV-2 infection and COVID-19 hospitalization decreased 2–4 months after the fourth dose. Four mRNA-1273 doses provided significant protection against COVID-19 outcomes compared with 3 doses, consistent in various subgroups of demographic and clinical characteristics, although rVE varied and waned over time.

The Paleoproterozoic Evolution of Basement Rocks of the Taebaeksan Basin, Korean Peninsula, and Their Correlation to Those of the Paleoproterozoic Massifs in the Korean Peninsula

The Korean Peninsula mainly comprises the Paleoproterozoic Gwanmo, Nangnim, Gyeonggi, and Yeongnam massifs from north to south. The Paleoproterozoic basement is rarely exposed in the Paleozoic Taebaeksan basin, which is located in the northeastern part of the Okcheon belt between the Gyeonggi and Yeongnam massifs. One of the most important issues in the tectonic interpretation of the Korean Peninsula is whether Paleoproterozoic rocks in the Taebaeksan basin have an affinity with those in the Gyeonggi or Yeongnam massifs. To solve this problem, we focused on the petrogenesis of the Imgye gabbroic diorite, Jungbongsan granite, and Jangsan quartzite in the Imgye area of the Taebaeksan basin. The Imgye gabbroic diorite shows mafic to intermediate compositions with slightly enriched LREEs compared to HREEs, slightly positive Rb, K, and Pb anomalies, and negative Ta, Nb, and P anomalies. The Imgye gabbroic diorite formed in a volcanic arc tectonic setting. The geochemical compositions of the Jungbongsan granite show enriched LREEs compared to HREEs with negative Eu anomalies, and reveal strong positive Rb, Th, K, and Pb anomalies with negative Ba, Ta, Nb, Sr, P, Eu, and Ti anomalies. This Jungbongsan granite also formed in an arc tectonic setting like the Imgye gabbroic diorite. LA-ICP-MS zircon age dating of the Imgye gabbroic diorite gives an intrusion age of 1948 ± 21 Ma, whereas SHRIMP U–Pb zircon age dating on the Jungbongsan granite yields an emplacement age of 1873 ± 14 Ma. The εHf(t) values of the Imgye gabbroic diorite are from 3.5 to 9.7, whereas those of the Jungbongsan granite are from −2.9 to 0.6. These data imply that the Imgye gabbroic diorite formed from a depleted mantle in the arc tectonic environment, whereas the Jungbongsan granite formed by reworking pre-existing crust material in the arc environment. The detrital zircons in the Jangsan quartzite show ages ranging from 3.06 to 1.85 Ga, with a peak concentration of ca. 2.5 Ga. Previous studies have suggested that the northern Gyeonggi and Nangnim massifs underwent collision-related magmatism and metamorphism at ca. 1.93–1.90 Ga, and then post-collisional magmatism and metamorphism at ca. 1.89–1.83 Ga, whereas the southern Gyeonggi massif underwent subduction-related magmatism and metamorphism at ca. 1.94–1.92 Ga, and then post-collision-related magmatism and metamorphism at ca. 1.84–1.78 Ga. By contrast, subduction-related events were recognized in the northern Yeongnam massif at ca 2.02–1.96 Ga and 1.90–1.85 Ga. This work, combined with the previous studies, suggests that the Paleoproterozoic basement in the Imgye area of the Taebaeksan basin can be correlated with the Paleoproterozoic basement of the northern Yeongnam massif rather than with those of the Nangnim and Gyeonggi massifs.

The association between Gabapentin or Pregabalin use and the risk of dementia: an analysis of the National Health Insurance Research Database in Taiwan.

Objective: Previous studies have shown that gabapentin or pregabalin use is associated with cognitive decline. Herein, we aimed to evaluate the association between gabapentin or pregabalin use and the risk of dementia. Methods: In this retrospective, population-based matched cohort study, all research data were collected from the 2005 Longitudinal Health Insurance Database, which contains data of 2million people randomly selected from the National Health Insurance Research Database of Taiwan in 2005. The study extracted data from 1 January 2000, to 31 December 2017. Adult patients taking gabapentin or pregabalin were included in the exposure group, and patients not using gabapentin or pregabalin matched to exposure subjects in a 1:5 ratio by propensity scores composed of age, sex and index date were included in the non-exposure group. Results: A total of 206,802 patients were enrolled in the study. Of them, 34,467 gabapentin- or pregabalin-exposure and 172,335 non-exposure patients were used for analysis. The mean follow-up day (±standard deviation) after the index date was 1724.76 (±1282.32) and 1881.45 (±1303.69) in the exposure and non-exposure groups, respectively; the incidence rates of dementia were 980.60 and 605.48 per 100,000 person-years, respectively. The multivariate-adjusted hazard ratio of risk of dementia for gabapentin or pregabalin exposure versus the matched non-exposed group was 1.45 (95% confidence interval [CI], 1.36-1.55). The risk of dementia increased with higher cumulative defined daily doses during the follow-up period. Moreover, the stratification analysis revealed that the risk of dementia associated with gabapentin or pregabalin exposure was significant in all age subgroups; however, it was higher in younger patients (age <50) than in the older patients (hazard ratio, 3.16; 95% CI, 2.23-4.47). Conclusion: Patients treated with gabapentin or pregabalin had an increased risk of dementia. Therefore, these drugs should be used with caution, particularly in susceptible individuals.

25-year trends in first-time hospitalizations for Parkinson's disease and subsequent mortality: A Danish nationwide cohort study

BackgroundIn most countries, incidence and mortality for Parkinson's disease (PD) have not been monitored by surveillance registries, although it could demonstrate the need for primary and tertiary prevention. ObjectiveTo examine 25-year trends in first-time hospitalizations for PD in Denmark and subsequent short and long-term mortality. MethodsIn a nationwide population-based cohort we identified all 34,947 individuals with a first-time hospitalization for PD from 1995 through 2019. We calculated standardized incidence rates of PD and 1-year and 5-year mortality by sex. Mortality rates were compared with a reference cohort randomly selected from the background population matched on sex, age, and index date. ResultsThe annual standardized incidence rate of PD was relatively stable during the study period in both men and women. The incidence of PD was higher in men than in women and with the highest incidence in those aged 70–79 years. One and 5-year mortality risk after first-time hospitalization for PD was similar for men and women, and decreased by around 30% and 20%, respectively, between 1995 and 2019. The matched reference cohort had a similar decline in mortality over time. ConclusionThe rate of first-time hospitalization for PD was relatively stable between 1995 and 2019, whereas subsequent short and long-term mortality declined during the period as in the reference cohort.

Association of oral bisphosphonates with cardioembolic ischemic stroke: a nested case-control study.

Background: Bisphosphonates have been reported to increase the risk of atrial fibrillation. Therefore, it is conceivable that they may increase the risk of cardioembolic ischemic stroke (IS). However, most epidemiological studies carried out thus far have not shown an increased risk of IS, though none separated by the main pathophysiologic IS subtype (cardioembolic and non-cardioembolic) which may be crucial. In this study, we tested the hypothesis that the use of oral bisphosphonates increases specifically the risk of cardioembolic IS, and explored the effect of treatment duration, as well as the potential interaction between oral bisphosphonates and calcium supplements and anticoagulants. Methods: We performed a case-control study nested in a cohort of patients aged 40-99years, using the Spanish primary healthcare database BIFAP, over the period 2002-2015. Incident cases of IS were identified and classified as cardioembolic or non-cardioembolic. Five controls per case were randomly selected, matched for age, sex, and index date (first recording of IS) using an incidence-density sampling. The association of IS (overall and by subtype) with the use of oral bisphosphonates within the last year before index date was assessed by computing the adjusted odds ratios (AOR) and their 95% CI using a conditional logistic regression. Only initiators of oral bisphosphonates were considered. Results: A total of 13,781 incident cases of IS and 65,909 controls were included. The mean age was 74.5 (SD ± 12.4) years and 51.6% were male. Among cases, 3.15% were current users of oral bisphosphonates, while among controls they were 2.62%, yielding an AOR of 1.15 (95% CI:1.01-1.30). Of all cases, 4,568 (33.1%) were classified as cardioembolic IS (matched with 21,697 controls) and 9,213 (66.9%) as non-cardioembolic IS (matched with 44,212 controls) yielding an AOR of 1.35 (95% CI:1.10-1.66) and 1.03 (95% CI: 0.88-1.21), respectively. The association with cardioembolic IS was clearly duration-dependent (AOR≤1year = 1.10; 95% CI:0.82-1.49; AOR>1-3years = 1.41; 95% CI:1.01-1.97; AOR>3years = 1.81; 95% CI:1.25-2.62; p for trend = 0.001) and completely blunted by anticoagulants, even in long-term users (AOR>1year = 0.59; 0.30-1.16). An interaction between oral bisphosphonates and calcium supplements was suggested. Conclusion: The use of oral bisphosphonates increases specifically the odds of cardioembolic IS, in a duration-dependent manner, while leaves materially unaffected the odds of non-cardioembolic IS.

Type 2 Diabetes Mellitus and Periodontitis: Bidirectional Association in Population-based 15-year Retrospective Cohorts.

A two-way relationship between periodontitis and diabetes has been proposed. However, bidirectional epidemiological observation is limited and inconsistent. Using the National Health Insurance Research Database of Taiwan (covering over 99% of the entire population), we aimed to estimate the development of diabetes in periodontitis patients or that of periodontitis in patients with type 2 diabetes mellitus (T2DM), respectively. A total of 11 011 patients with severe periodontitis were recruited from 2000 to 2015. After matching by age, sex, and index date, 11 011 patients with mild periodontitis and 11 011 non-periodontitis controls were registered. Additionally, 157 798 patients with T2DM and 157 798 non-T2DM controls were enrolled, in whom the development of periodontitis was traced. Cox proportional hazards model was performed. Periodontitis patients tended to have a statistically high risk for T2DM. The adjusted hazard ratio was 1.94 (95% CI, 1.49-2.63, P < .01) and 1.72 (95% CI, 1.24-2.52, P < .01) for severe and mild periodontitis groups, respectively. The patients with severe periodontitis had a higher risk of having T2DM relative to those with mild periodontitis (1.17 [95% CI, 1.04-1.26, P < .001]). Conversely, the risk of periodontitis increased significantly in patients with T2DM (1.99 [95% CI, 1.42-2.48, P < .01]). However, high risk was observed for the outcome of severe periodontitis (2.08 [95% CI, 1.50-2.66, P < .001]), but not for mild periodontitis (0.97 [95% CI, 0.38-1.57, P = .462]). We suggest that the bidirectional association is between T2DM and severe but not mild periodontitis.

Capturing species‐wide diversity of the gut microbiota and its relationship with genomic variation in the critically endangered kākāpō

AbstractGut microbiota play an essential role in host health with important implications for conservation management of threatened wildlife. While factors such as diet, medication and habitat are known to shape the microbiota, our understanding of the entirety of factors, including the complex role of host genomic background, remains incomplete. Our research on the interaction between the host genome and gut microbiota of the critically endangered kākāpō (Strigops habroptilus), a flightless parrot endemic to Aotearoa New Zealand, represents, to our knowledge, one of the most comprehensive studies of the gastrointestinal bacterial diversity and its relationship with host genomic diversity for virtually an entire threatened species. We conducted a 16S rRNA gene‐based analysis of faecal samples representing the gut microbiota for 84% of kākāpō. This survey was leveraged with exceptional metadata to tease apart the impact of host genomic diversity and factors including sex, age, diet, antibiotics, disease, habitat and sampling date on the kākāpō gut microbiota. We find evidence of a highly polygenic genomic architecture of the gut microbiota and identify putative associations between bacterial diversity and functional pathways related to intestinal homeostasis, inflammation, immunity and metabolism. This improved understanding of the kākāpō gut microbiota—and its relationship with host genomics—can directly benefit kākāpō conservation by providing new insights into the role of the gut microbiome in kākāpō health and disease mitigation. Overall, we anticipate that an integration of microbiome studies in conservation research and management will improve our understanding and realisation of the One Health concept.

Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection

ObjectivesTo compare the long-term cumulative risk of SARS-CoV-2 infection associated with natural and vaccine-induced immunity. MethodsRetrospective population-based cohort study based on registry of COVID-19 vaccinations and SARS-CoV-2 infections among 9.1 million citizens of Lombardy, Italy, eligible for vaccination on 27th December 2020. Those who developed SARS-CoV-2 infection from 24th May to 14th September 2021, provided they did not yet receive the COVID-19 vaccine when infection was confirmed, and those who received the second mRNA vaccine dose, provided they had not yet developed the infection, were selected to be 1:1 matched for sex, age and index date. The latter corresponded to 90 days after confirmed infection or 14 days after vaccine administration. A control cohort including citizens who, on the index date, had neither developed infection nor received vaccination was also selected. Kaplan–Meier curves were used for comparing the cumulative incidence of new SARS-CoV-2 infection from the index date until 22nd June 2022. ResultsOverall, 19,418 1:1:1 risk-sets were included. After 9 months of follow-up, the cumulative risk of new SARS-CoV-2 infection was 21.8%, 22.0%, and 25.9%, respectively, among exposed to natural immunity, vaccine-induced immunity and unexposed. ConclusionsEquivalent potential for protecting against new SARS-CoV-2 infection was observed.

Comparison of non-invasive ventilation use and outcomes in children with Down syndrome and other children using this technology

Rationale Children with Down syndrome (DS) make up a substantial portion of long-term non-invasive ventilation (LT-NIV) users though it is unclear if their unique features alter LT-NIV efficacy or use. The aim of this study is to compare the use and outcomes of LT-NIV for children with DS and a matched comparison (MCG). Methods This is a sub-study of a 10-year retrospective review of children initiated on LT-NIV in Alberta, Canada ( N = 622). Children with DS ( n = 106) were matched in a 1:2 ratio with other children using LT-NIV based on age and therapy start date. Data was collected from medical and sleep laboratory records. Results Upper airway disease was the most common indication for LT-NIV in both groups, though was higher in children with DS (DS: 90% vs. MCG: 50%, OR 8.64 [95% CI 4.38–17.04]). Sleep and respiratory parameters, at the baseline diagnostic sleep study and the change from baseline to treatment study, did not differ between groups. Nasal masks were the predominant mask type in both children with DS (55%) and the MCG (66%) with more children with DS, compared to the MCG, using full face masks (DS: 45 vs. MCG: 33%, p &amp;lt; 0.05). Continuous positive airway pressure was used more often in children with DS (93.3% vs. 69.2%, p &amp;lt; 0.001) while bilevel-positive airway pressure was more common in the MCG (DS: 6.7% vs. MCG 30.8%, p &amp;lt; 0.001). Children with DS were followed longer than children in the MCG (DS: 2.4 [IQR 2.8] vs. MCG: 1.8 [IQR 2.7] years, p &amp;lt; 0.05). Adherence was lower in children with DS at both 6–12 month follow-up and most recent visit with a similar decrease in adherence in both groups over the follow-up period (0.0 [IQR 1.4] vs. −0.3 [IQR 2.0]. Despite this, 66% and 49% of children with DS used LT-NIV for more than 4 h/night at the 6–12 month and most current visit, respectively. Discontinuation of LT-NIV and mortality did not differ between groups. Conclusion LT-NIV is a common and efficacious treatment in children with DS used predominantly for upper airway obstruction. While adherence is lower, the majority of children with DS are successful at using LT-NIV.

Basic forms (genres) of literature and the relationship between poetry and drama

The research entitled (Basic Forms of Literature and the Relationship between Poetry and Drama) is an attempt to present accurate information about the genres of literature and point out the differences and relationships between them. In order to find the relationship between poetry and drama, which is the main purpose of our research, the beginnings of distinguishing literary genres go back to Aristotle's book on the art of poetry. That is, the classification that existed from the beginning until the Middle Ages dates back to the time of Aristotle, but what exists today, although there are differences between them, there are many commonalities and similarities between the elements and genders. Through its results, the research describes the relationship between drama and poetry as a historical century and from there goes to find the closest points of the relationship between poetry and drama.

Severe lupus flare is associated with a much higher risk of stroke among patients with SLE.

There are few data on the influence of lupus flare on stroke risk in systemic lupus erythematosus (SLE). In this study, we examined whether a severe lupus flare further increases the risk of stroke among SLE patients. Using the Taiwan's National Health Insurance Research Database, we conducted a retrospective population-based cohort study from 2000 to 2016. Each patient with SLE was matched to a non-SLE subject in age, sex, and index date. A severe flare of lupus was identified when an SLE patient was admitted for pulse therapy with intravenous methylprednisolone greater than 250 mg in a single hospitalization. SLE patients were divided into severe flare and non-severe flare groups. In total, 334 of 10,006 patients with SLE had a severe lupus flare, and the remaining 9672 patients were assigned to the non-severe flare group. Ischemic stroke occurred in 29 (8.7%), 485 (5%), and 384 (3.8%) of the patients in the severe flare, non-severe flare, and control groups, respectively. Hemorrhagic stroke occurred in 9 (2.7%), 123 (1.3%), and 37 (0.4%) of patients in the severe flare, non-severe flare, and control groups, respectively. Compared with patients in the non-severe flare group, patients with severe flare had a significantly higher risk of ischemic stroke (adjusted hazard ratio (aHR) = 7.44, 95% confidence interval (CI): 4.93-11.25 vs aHR = 1.52, 95% CI: 1.26-1.83) and hemorrhagic stroke (aHR = 22.49, 95% CI: 10.09-50.12 vs aHR = 4.47, 95% CI: 2.90-6.90). Severe lupus flare is associated with a much higher risk of ischemic and hemorrhagic strokes among SLE patients.